Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioCardia Inc BCDA

BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and... see more

Bullboard (NDAQ:BCDA)

View:
Post by Iseneschalon Feb 03, 2022 10:10am

BCDA ...... Ya I"m pissed at the SH audience

I give u dbags good advice.......u can all kiss mt brown eye !!!!
Post by Iseneschalon Feb 03, 2022 10:04am

BCDA ..... Yeeha ..... Cha F'king Ching !!!!!

Cheers ; )  So much for my reputation ..... Maddapakkas !!!!!!!!!!!!!!!!
Post by Iseneschalon Feb 03, 2022 9:56am

BCDA .....2 Reverse Splits.... I'd say

There's a lot of people buried and they want their money back  I believe this will run  JMHO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities